NCT04937699View on ClinicalTrials.gov

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,690

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Coronary SyndromePercutaneous Coronary Intervention
Interventions
DRUG

Standard-DAPT of Ticagrelor plus aspirin

Ticagrelor 90mg bid+Aspirin 100mg qd for 1 month after PCI, Randomized subjects continue for another 11 months

DRUG

Sequential monotherapy of Ticagrelor and clopidogrel

Ticagrelor 90mg bid+Aspirin 100mg qd for 1 month after PCI, Randomized subjects switch to ticagrelor 90mg bid for 5 months; then clopidogrel 75mg qd, for another 6 months.

Trial Locations (1)

310009

RECRUITING

2nd Affiliated Hospital, School of Medicine at Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER